Cronos Group, Inc. (CRON)
3.38
-0.01
(-0.30%)
USD |
NASDAQ |
Aug 28, 16:00
3.375
0.00 (0.00%)
After-Hours: 20:00
Cronos Group Price : 3.38 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 3.40 | 3.421 | 3.31 | 3.38 | 1.239M |
| Aug 27, 2026 | 3.55 | 3.608 | 3.38 | 3.39 | 2.298M |
| Aug 26, 2026 | 3.49 | 3.58 | 3.48 | 3.55 | 1.421M |
| Aug 25, 2026 | 3.47 | 3.555 | 3.40 | 3.51 | 2.464M |
| Aug 24, 2026 | 3.31 | 3.45 | 3.27 | 3.41 | 2.217M |
| Aug 21, 2026 | 3.23 | 3.32 | 3.22 | 3.31 | 1.314M |
| Aug 20, 2026 | 3.275 | 3.299 | 3.21 | 3.22 | 998130.0 |
| Aug 19, 2026 | 3.21 | 3.30 | 3.21 | 3.29 | 1.375M |
| Aug 18, 2026 | 3.14 | 3.24 | 3.13 | 3.21 | 1.048M |
| Aug 17, 2026 | 3.14 | 3.18 | 3.12 | 3.15 | 1.331M |
| Aug 14, 2026 | 3.15 | 3.16 | 3.045 | 3.14 | 1.027M |
| Aug 13, 2026 | 3.17 | 3.31 | 3.15 | 3.16 | 1.515M |
| Aug 12, 2026 | 3.06 | 3.175 | 3.04 | 3.17 | 2.052M |
| Aug 11, 2026 | 3.04 | 3.09 | 3.01 | 3.08 | 1.206M |
| Aug 10, 2026 | 3.08 | 3.11 | 2.99 | 3.00 | 1.658M |
| Aug 07, 2026 | 3.13 | 3.17 | 3.065 | 3.10 | 2.086M |
| Aug 06, 2026 | 3.02 | 3.12 | 2.902 | 3.07 | 5.700M |
| Aug 05, 2026 | 2.81 | 2.81 | 2.685 | 2.72 | 1.718M |
| Aug 04, 2026 | 2.84 | 2.865 | 2.79 | 2.81 | 1.402M |
| Aug 03, 2026 | 2.84 | 2.89 | 2.82 | 2.83 | 901735.0 |
| Jul 31, 2026 | 2.89 | 2.90 | 2.81 | 2.83 | 728458.0 |
| Jul 30, 2026 | 2.87 | 2.91 | 2.855 | 2.89 | 822811.0 |
| Jul 29, 2026 | 2.85 | 2.879 | 2.825 | 2.86 | 1.062M |
| Jul 28, 2026 | 2.85 | 2.87 | 2.83 | 2.85 | 828156.0 |
| Jul 27, 2026 | 2.82 | 2.88 | 2.76 | 2.86 | 1.065M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Lexaria Bioscience Corp. | 10.35 |
| Target Group, Inc. (Canada) | 0.0012 |
| Tilray Brands, Inc. | 4.59 |
| InMed Pharmaceuticals, Inc. | 1.38 |
| NervGen Pharma Corp. | 2.28 |
Price Related Metrics
| PE Ratio | 18.35 |
| PS Ratio | 7.193 |
| PEG Ratio | 0.0639 |
| Price to Book Value | 1.172 |
| Price to Free Cash Flow | 25.96 |
| Earnings Yield | 5.45% |
| Market Cap | 1.253B |
| PEGY Ratio | 0.0639 |
| Normalized PE Ratio | 17.07 |